Circulating Cell-Free DNA An Up-Coming Molecular Marker in Exercise Physiology

被引:162
|
作者
Breitbach, Sarah [1 ]
Tug, Suzan [1 ]
Simon, Perikles [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Sports Med, Fac Social Sci Media & Sport, D-55128 Mainz, Germany
关键词
FREE PLASMA DNA; RESISTANCE EXERCISE; HUMAN-LEUKOCYTES; SKELETAL-MUSCLE; FETAL DNA; LYMPHOCYTE APOPTOSIS; BIOCHEMICAL MARKERS; ECCENTRIC EXERCISE; STRENUOUS EXERCISE; XANTHINE-OXIDASE;
D O I
10.2165/11631380-000000000-00000
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The phenomenon of circulating cell-free DNA (cfDNA) concentrations is of importance for many biomedical disciplines including the field of exercise physiology. Increases of cfDNA due to exercise are described to be a potential hallmark for the overtraining syndrome and might be related to, or trigger adaptations of, immune function induced by strenuous exercise. At the same time, exercise provides a practicable model for studying the phenomenon of cfDNA that is described to be of pathophysiological relevance for different topics in clinical medicine like autoimmune diseases and cancer. In this review, we are summarizing the current knowledge of exercise-based acute and chronic alterations in cfDNA levels and their physiological significance. The effects of acute exercise on cfDNA concentrations have been investigated in resistance exercises and in continuous, stepwise and interval endurance exercises of different durations. cfDNA concentrations peaked immediately after acute exercise and showed a rapid return to baseline levels. Typical markers of skeletal muscle damage (creatine kinase, uric acid, C-reactive protein) show delayed kinetics compared with the cfDNA peak response. Exercise parameters such as intensity, duration or average energy expenditure do not explain the extent of increasing cfDNA concentrations after strenuous exercise. This could be due to complex processes inside the human organism during and after physical activity. Therefore, we hypothesize composite effects of different physiological stress parameters that come along with exercise to be responsible for increasing cfDNA concentrations. We suggest that due to acute stress, cfDNA levels increase rapidly by a spontaneous active or passive release mechanism that is not yet known. As a result of the rapid and parallel increase of cfDNA and lactate in an incremental treadmill test leading to exhaustion within 15-20 minutes, it is unlikely that cfDNA is released into the plasma by typical necrosis or apoptosis of cells in acute exercise settings. Recently, rapid DNA release mechanisms of activated immune-competent cells like NETosis (pathogen-induced cell death including the release of neutrophil extracellular traps [NETs]) have been discovered. cfDNA accumulations might comprise a similar kind of cell death including trap formation or an active release of cfDNA. Just like chronic diseases, chronic high-intensity resistance training protocols induced persistent increases of cfDNA levels. Chronic, strenuous exercise protocols, either long-duration endurance exercise or regular high-intensity workouts, induce chronic inflammation that might lead to a slow, constant release of DNA. This could be due to mechanisms of cell death like apoptosis or necrosis. Yet, it has neither been implicated nor proven sufficiently whether cfDNA can serve as a marker for overtraining. The relevance of cfDNA with regard to overtraining status, performance level, and the degree of physical exhaustion still remains unclear. Longitudinal studies are required that take into account standardized and controlled exercise, serial blood sampling, and large and homogeneous cohorts of different athletic achievement. Furthermore, it is important to establish standardized laboratory procedures for the measurement of genomic cfDNA concentrations by quantitative real-time polymerase chain reaction (PCR). We introduce a new hypothesis based on acute exercise and chronic exposure to stress, and rapid active and passive chronic release of cfDNA fragments into the circulation.
引用
收藏
页码:565 / 586
页数:22
相关论文
共 50 条
  • [41] Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
    Hu, Ying
    Chen, Yawei
    Guo, Hao
    Yu, Jianing
    Chen, Yanhui
    Liu, Yang
    Lan, Ling
    Li, Jian
    Wang, Huaqing
    Zhang, Henghui
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5159 - 5167
  • [42] Molecular characterization and functional roles of circulating cell-free extrachromosomal circular DNA
    Li, Dandan
    Qian, Xia
    Wang, Yingjie
    Yin, Yicong
    Sun, Huishan
    Zhao, Haitao
    Wu, Jie
    Qiu, Ling
    [J]. CLINICA CHIMICA ACTA, 2024, 556
  • [43] Association Of Circulating Cell-free Dna Released During Physical Exercise With Extracellular Vesicles
    Neuberger, Elmo
    Brahmer, Alexandra
    Boztepe, Berin
    Kraemer-Albers, Eva-Maria
    Simon, Perikles
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2019, 51 (06): : 576 - 576
  • [44] Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer
    Papadopoulou, E
    Davilas, E
    Sotiriou, V
    Koliopanos, A
    Aggelakis, F
    Dardoufas, K
    Agnanti, NJ
    Karydas, L
    Nasioulas, G
    [J]. ONCOLOGY RESEARCH, 2004, 14 (09) : 439 - 445
  • [45] DNA methylation in circulating cell-free DNA of nasopharyngeal carcinoma
    Xu, Yifei
    Ma, Ning
    Midorikawa, Kaoru
    Hiraku, Yusuke
    Oikawa, Shinji
    Zhang, Zhe
    Huang, Guangwu
    Takeuchi, Kazuhiko
    Murata, Mariko
    [J]. CANCER SCIENCE, 2018, 109 : 529 - 529
  • [46] Circulating cell-free DNA: A promising marker of regional lymphonode metastasis in breast cancer patients
    Agostini, M.
    Enzo, M. V.
    Bedin, C.
    Belardinelli, V.
    Goldin, E.
    Del Bianco, P.
    Maschietto, E.
    D'Angelo, E.
    Izzi, Leo
    Saccani, A.
    Zavagno, G.
    Nitti, D.
    [J]. CANCER BIOMARKERS, 2012, 11 (2-3) : 89 - 98
  • [47] Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
    Li, Yunhui
    Liang, Bin
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
    Del Re, Marzia
    Bordi, Paola
    Rofi, Eleonora
    Restante, Giuliana
    Valleggi, Simona
    Minari, Roberta
    Crucitta, Stefania
    Arrigoni, Elena
    Chella, Antonio
    Morganti, Riccardo
    Tiseo, Marcello
    Petrini, Iacopo
    Danesi, Romano
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (10) : 1252 - 1258
  • [49] Circulating cell-free mitochondrial DNA fragment: A possible marker for early detection of Schistosoma japonicum
    Ullah, Hanif
    Arbab, Safia
    Khan, Muhammad Inayat Ullah
    Li, Ka
    Muhammad, Nehaz
    Suleman
    Qadeer, Abdul
    Dan, Wang
    Sato, Marcello Otake
    [J]. INFECTION GENETICS AND EVOLUTION, 2021, 88
  • [50] Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
    Wiersma, Marit
    van Marion, Denise M. S.
    Bouman, Emma J.
    Li, Jin
    Zhang, Deli
    Ramos, Kennedy S.
    Lanters, Eva A. H.
    de Groot, Natasja M. S.
    Brundel, Bianca J. J. M.
    [J]. CELLS, 2020, 9 (05)